Mpex Pharmaceuticals
Latest round
- Series D
Last raised
- Feb 2009
Total raised
- $75M
Investors
- 6
About Mpex Pharmaceuticals
Mpex Pharmaceuticals Inc.Founded in 2001, Mpex Pharmaceuticals Inc. specializes in developing novel therapies for infectious diseases. The company has undergone significant developments in its business strategy over the years., which announced its intent to acquire the company in April 2011.Mpex Pharmaceuticals offers a portfolio of innovative therapeutic solutions tailored for the healthcare sector. Its flagship product integrates advanced technology to enhance user experience and improve operational efficiencies, particularly in the management of infectious diseases.The revenue model of Mpex Pharmaceuticals is based on subscription-based services and direct sales to healthcare providers. Clients typically engage via long-term agreements that offer access to proprietary treatments and technologies.Mpex Pharmaceuticals is focused on expanding its product offerings with new therapeutic developments planned for launch in 2023. The company aims to penetrate additional markets in Europe and Asia by the end of 2024.
Who invested in Mpex Pharmaceuticals
6 investors across 3 rounds
See all investors in Mpex Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Mpex Pharmaceuticals
Who invested in Mpex Pharmaceuticals?
Mpex Pharmaceuticals has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mpex Pharmaceuticals raised?
Mpex Pharmaceuticals has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Mpex Pharmaceuticals last raise money?
Mpex Pharmaceuticals's most recent round on record is a Series D, in Feb 2009.
What does Mpex Pharmaceuticals do?
Mpex Pharmaceuticals is a biotechnology company.
Where is Mpex Pharmaceuticals headquartered?
Mpex Pharmaceuticals is headquartered in San Diego, US.
Which VCs invest in companies like Mpex Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Mpex Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Mpex Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.